Cargando…

Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases

Puerarin, an isoflavone glycoside derived from Pueraria lobata (Willd.) Ohwi, has been identified as a pharmacologically active component with diverse benefits. A large number of experimental and clinical studies have demonstrated that puerarin is widely used in the treatment of a variety of disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yan-Xi, Zhang, Hong, Peng, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689134/ https://www.ncbi.nlm.nih.gov/pubmed/34950032 http://dx.doi.org/10.3389/fphar.2021.771793

Ejemplares similares

Puerarin Prevents Acute Liver Injury via Inhibiting Inflammatory Responses and ZEB2 Expression
por: Yang, Junfa, et al.
Publicado: (2021)

Puerarin Exerts Protective Effects on Wear Particle-Induced Inflammatory Osteolysis
por: Yang, Chao, et al.
Publicado: (2019)

Puerarin Ameliorates Caerulein-Induced Chronic Pancreatitis via Inhibition of MAPK Signaling Pathway
por: Zeng, Xiang-Peng, et al.
Publicado: (2021)

Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases
por: Wang, Qian, et al.
Publicado: (2022)

Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
por: Zhou, Bu-Gao, et al.
Publicado: (2018)

Molecular Mechanism of Puerarin Against Diabetes and its Complications
por: Bai, Yi-ling, et al.
Publicado: (2022)

Puerarin: A protective drug against ischemia-reperfusion injury
por: Gao, Minglang, et al.
Publicado: (2022)

Puerarin inhibits EMT induced by oxaliplatin via targeting carbonic anhydrase XII
por: Chen, Xindong, et al.
Publicado: (2022)

Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats
por: Cai, Shao-Ai, et al.
Publicado: (2018)

Integrating network pharmacology and experimental verification to explore the mechanism of puerarin against oliguria in acute alcoholism
por: Wan, Mei-Xuan, et al.
Publicado: (2022)

Puerarin Restores Autophagosome-Lysosome Fusion to Alleviate Cadmium-Induced Autophagy Blockade via Restoring the Expression of Rab7 in Hepatocytes
por: Wang, Tao, et al.
Publicado: (2021)

Effects of Puerarin Combined with PLGA/TCP/Puerarin on Osteocalcin and Sialoprotein of Mandibular Defects
por: Guo, Ying, et al.
Publicado: (2022)

Puerarin Increases Survival and Protects Against Organ Injury by Suppressing NF-κB/JNK Signaling in Experimental Sepsis
por: Wang, Lei, et al.
Publicado: (2020)

Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway
por: Zhang, Qianqian, et al.
Publicado: (2023)

Puerarin Relieves Paclitaxel-Induced Neuropathic Pain: The Role of Na(v)1.8 β1 Subunit of Sensory Neurons
por: Zhang, Xiao-Long, et al.
Publicado: (2019)

Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection
por: Liang, Weizheng, et al.
Publicado: (2022)

Puerarin Alleviates Depression-Like Behavior Induced by High-Fat Diet Combined With Chronic Unpredictable Mild Stress via Repairing TLR4-Induced Inflammatory Damages and Phospholipid Metabolism Disorders
por: Gao, Li-Na, et al.
Publicado: (2021)

Natural AMPK Activators in Cardiovascular Disease Prevention
por: Heidary Moghaddam, Reza, et al.
Publicado: (2022)

Effects of puerarin on the pharmacokinetics of triptolide in rats
por: Wang, Qingfa, et al.
Publicado: (2019)

Editorial: Efficacy and mechanism of herbal medicines and their functional compounds in preventing and treating cardiovascular diseases and cardiovascular disease risk factors
por: Meng, Tiantian, et al.
Publicado: (2023)

Integrating Evidence of the Traditional Chinese Medicine Collateral Disease Theory in Prevention and Treatment of Cardiovascular Continuum
por: Cheang, Iokfai, et al.
Publicado: (2022)

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
por: Long, Hui-Zhi, et al.
Publicado: (2021)

Puerarin promotes osteogenesis and inhibits adipogenesis in vitro
por: Wang, Nan, et al.
Publicado: (2013)

Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles
por: Luo, Cheng-Feng, et al.
Publicado: (2013)

Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update
por: Yu, Chao-Chao, et al.
Publicado: (2022)

RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases
por: Zhou, Wanwan, et al.
Publicado: (2021)

Network pharmacology-based analysis of the effects of puerarin on sarcopenia
por: Chen, Xufeng, et al.
Publicado: (2022)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases
por: Ma, Jiahui, et al.
Publicado: (2022)

Effect of puerarin on human choriocarcinoma cells
por: Lidao, Bao, et al.
Publicado: (2015)

Research on the Effect of Puerarin on Alleviating Sports Fatigue
por: Wei, Zhang
Publicado: (2015)

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2022)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Exosomes: A Novel Strategy for Treatment and Prevention of Diseases
por: Wang, Jiaqi, et al.
Publicado: (2017)

Role of omega-3 fatty acids in the prevention and treatment of cardiovascular Diseases: A consensus statement from the Experts’ Committee Of National Society Of Cardiometabolic Medicine
por: Li, Jian-Jun, et al.
Publicado: (2022)

Lignin/Puerarin Nanoparticle-Incorporated Hydrogel Improves Angiogenesis through Puerarin-Induced Autophagy Activation
por: Pan, Yingjing, et al.
Publicado: (2023)

Chronopharmacokinetics of Puerarin in Diabetic Rats
por: Zhang, C. T., et al.
Publicado: (2013)

Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma
por: ZENG, YAN-PING, et al.
Publicado: (2014)

Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
por: Liang, Zhe, et al.
Publicado: (2021)

Mechanism and Potential Target of Blood-Activating Chinese Botanical Drugs Combined With Anti-Platelet Drugs: Prevention and Treatment of Atherosclerotic Cardiovascular Diseases
por: Li, Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mgin83lm736cdfb73h1bjdtlcf